×

What are you searching for?




Healthcare

4 Min read

AIM IMMUNO TECH SIGNS MATERIAL TRANSFER AND RESEARCH AGREEMENT WITH NIID AND SHINOGI

Published On 10 Jul 2020 08:16 AM


SHARE THIS ARTICLE  


HIGHLIGHTS

  • AIM ImmunoTech signs Material Transfer and Research Agreement with the National Institute of Infectious Diseases (Japan) and Shionogi.
  • Shinogi is a Leading Global Pharmaceutical Company.
  • Agreement stipulates the testing an ampligen as a potential vaccine adjuvant for COVID-19.

AIM ImmunoTech has signed a material transfer and research agreement with Japan'....


Tags : AIM ImmunoTech, Shionogi, National Institute of Infectious Diseases, NIID, Ampligen, pharmaceuticals,
SHARE THIS ARTICLE  

Leave a comment 

comments (0)